Targeted Approaches to Weight Control for Young Adults Grant with RCU Proposal

RCU 提案为年轻人提供有针对性的体重控制方法

基本信息

  • 批准号:
    8296227
  • 负责人:
  • 金额:
    $ 95.16万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-08-17 至 2014-05-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Obesity represents a chronic disease associated with significant cardiovascular disease (CVD) morbidity and mortality. Weight gain in young adults adversely impacts the development of CVD risk factors. Further, there is a clear relationship between weight loss in obese persons and reduction in these CVD risk factors. Unfortunately, young adults are at high risk for weight gain. Although the scientific literature contains a number of reports regarding successful weight loss efficacy studies, young adults are typically underrepresented. Cigarette smoking is the leading preventable cause of morbidity and mortality, but quitting smoking results in significant weight gain. Tobacco quit lines have been shown to help persons quit smoking. However, concerns about post-cessation weight gain have been reported as a significant barrier to quitting. If an efficacious behavioral weight loss program could be combined with an efficacious behavioral smoking cessation program that prevented post-cessation weight gain, then a large public health benefit may result. Such a combined weight loss / smoking cessation program that used targeted intervention strategies to young adults, removed barriers to participation, and utilize interactive technology should be appealing to this age group. To date such a combined program has not been tested in young overweight and obese cigarette smokers trying to quit. Therefore, the objective of this clinical trial is to develop and test a behavioral weight loss intervention delivered through interactive technology that can be used in conjunction with an efficacious tobacco quit line (QL). A total of 330 participants will be necessary to adequately address the following specific aims: Primary Aim: We hypothesize that an efficacious proactive tobacco quit line plus a behavioral weight loss intervention delivered through interactive technology (Intervention Group) will significantly attenuate or prevent weight gain associated with smoking cessation at 2 years after enrollment compared to a proactive tobacco quit line alone (Comparison Group) in young overweight and obese smokers. Secondary Aims: We also plan to assess changes between the groups in: a.) Biochemically verified smoking cessation; b.) Diet and eating behavior; and c.) Physical activity. (End of Abstract)
描述(由申请人提供):肥胖是一种与显著心血管疾病(CVD)发病率和死亡率相关的慢性疾病。年轻人的体重增加对CVD危险因素的发展产生不利影响。此外,肥胖者的体重减轻与这些CVD风险因素的减少之间存在明显的关系。不幸的是,年轻人体重增加的风险很高。虽然科学文献包含了一些关于成功减肥功效研究的报告,但年轻人通常代表性不足。吸烟是发病率和死亡率的主要可预防原因,但戒烟会导致体重显著增加。戒烟热线已被证明可以帮助人们戒烟。然而,据报道,对戒烟后体重增加的担忧是戒烟的一个重要障碍。如果一个有效的行为减肥计划可以与一个有效的行为戒烟计划,防止戒烟后体重增加相结合,那么一个大的公共卫生效益可能会导致。这样一个结合减肥/戒烟的计划,对年轻人使用有针对性的干预策略,消除了参与的障碍,并利用互动技术,应该对这个年龄组有吸引力。到目前为止,这种联合方案还没有在试图戒烟的年轻超重和肥胖吸烟者中进行过测试。因此,本临床试验的目的是开发和测试一种通过互动技术提供的行为减肥干预,该干预可与有效的戒烟线(QL)结合使用。总共需要330名参与者,以充分实现以下具体目标:我们假设,一个有效的主动戒烟线加上行为减肥干预通过互动技术提供与单独的主动戒烟线相比,(干预组)将在入组后2年显著减轻或预防与戒烟相关的体重增加(对照组)在年轻超重和肥胖吸烟者。次要目的:我们还计划评估各组之间的变化:a.)经生物化学验证的戒烟; B.)饮食和饮食行为;以及c.)体力活动。 (End摘要)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KAREN C JOHNSON其他文献

KAREN C JOHNSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KAREN C JOHNSON', 18)}}的其他基金

Managing Obesity by Leveraging Health Information Technology to Lower Cancer Risk
利用健康信息技术控制肥胖以降低癌症风险
  • 批准号:
    10355938
  • 财政年份:
    2022
  • 资助金额:
    $ 95.16万
  • 项目类别:
Managing Obesity by Leveraging Health Information Technology to Lower Cancer Risk
利用健康信息技术控制肥胖以降低癌症风险
  • 批准号:
    10551269
  • 财政年份:
    2022
  • 资助金额:
    $ 95.16万
  • 项目类别:
Intensive Lifestyle Intervention, Metabolomics, and Risk of Frailty Fracture in Overweight or Obese Patients with Type 2 Diabetes
超重或肥胖 2 型糖尿病患者的强化生活方式干预、代谢组学和衰弱性骨折风险
  • 批准号:
    10661065
  • 财政年份:
    2021
  • 资助金额:
    $ 95.16万
  • 项目类别:
Intensive Lifestyle Intervention, Metabolomics, and Risk of Frailty Fracture in Overweight or Obese Patients with Type 2 Diabetes
超重或肥胖 2 型糖尿病患者的强化生活方式干预、代谢组学和衰弱性骨折风险
  • 批准号:
    10490260
  • 财政年份:
    2021
  • 资助金额:
    $ 95.16万
  • 项目类别:
Intensive Lifestyle Intervention, Metabolomics, and Risk of Frailty Fracture in Overweight or Obese Patients with Type 2 Diabetes
超重或肥胖 2 型糖尿病患者的强化生活方式干预、代谢组学和衰弱性骨折风险
  • 批准号:
    10205545
  • 财政年份:
    2021
  • 资助金额:
    $ 95.16万
  • 项目类别:
Targeted Approaches to Weight Control for Young Adults Grant with RCU Proposal
RCU 提案为年轻人提供有针对性的体重控制方法
  • 批准号:
    7918062
  • 财政年份:
    2009
  • 资助金额:
    $ 95.16万
  • 项目类别:
Targeted Approaches to Weight Control for Young Adults Grant with RCU Proposal
RCU 提案为年轻人提供有针对性的体重控制方法
  • 批准号:
    8101066
  • 财政年份:
    2009
  • 资助金额:
    $ 95.16万
  • 项目类别:
Targeted Approaches to Weight Control for Young Adults Grant with RCU Proposal
RCU 提案为年轻人提供有针对性的体重控制方法
  • 批准号:
    8481573
  • 财政年份:
    2009
  • 资助金额:
    $ 95.16万
  • 项目类别:
Targeted Approaches to Weight Control for Young Adults Grant with RCU Proposal
RCU 提案为年轻人提供有针对性的体重控制方法
  • 批准号:
    7700945
  • 财政年份:
    2009
  • 资助金额:
    $ 95.16万
  • 项目类别:
A Clinical Trial of Two Medications on Smoking Cessation
两种戒烟药物的临床试验
  • 批准号:
    6430710
  • 财政年份:
    2002
  • 资助金额:
    $ 95.16万
  • 项目类别:

相似海外基金

A platform for rapidly generating live attenuated enterovirus vaccines
快速生成减毒肠道病毒活疫苗的平台
  • 批准号:
    24K02286
  • 财政年份:
    2024
  • 资助金额:
    $ 95.16万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
I-Corps: Translation potential of an efficient method to generate live-attenuated and replication-defective DNA viruses for vaccine development
I-Corps:一种有效方法的转化潜力,可生成用于疫苗开发的减毒活病毒和复制缺陷型 DNA 病毒
  • 批准号:
    2420924
  • 财政年份:
    2024
  • 资助金额:
    $ 95.16万
  • 项目类别:
    Standard Grant
Developing a robust native extracellular matrix to improve islet function with attenuated immunogenicity for transplantation
开发强大的天然细胞外基质,以改善胰岛功能,并减弱移植的免疫原性
  • 批准号:
    10596047
  • 财政年份:
    2023
  • 资助金额:
    $ 95.16万
  • 项目类别:
Live attenuated non-transmissible (LANT) Klebsiella pneumoniae vaccines
肺炎克雷伯氏菌减毒非传染性 (LANT) 活疫苗
  • 批准号:
    10742028
  • 财政年份:
    2023
  • 资助金额:
    $ 95.16万
  • 项目类别:
Protecting Pigs From Enzootic Pneumonia: Rational Design Of Safe Attenuated Vaccines.
保护猪免受地方性肺炎:安全减毒疫苗的合理设计。
  • 批准号:
    BB/X017540/1
  • 财政年份:
    2023
  • 资助金额:
    $ 95.16万
  • 项目类别:
    Research Grant
A “Goldilocks” live attenuated poultry vaccine for Infectious Coryza
用于传染性鼻炎的“Goldilocks”家禽减毒活疫苗
  • 批准号:
    LP210301365
  • 财政年份:
    2023
  • 资助金额:
    $ 95.16万
  • 项目类别:
    Linkage Projects
A novel live-attenuated Zika vaccine with a modified 5'UTR
一种带有改良 5UTR 的新型寨卡减毒活疫苗
  • 批准号:
    10730832
  • 财政年份:
    2023
  • 资助金额:
    $ 95.16万
  • 项目类别:
Combating melanoma with an attenuated bacterial therapeutic
用减毒细菌疗法对抗黑色素瘤
  • 批准号:
    10659841
  • 财政年份:
    2023
  • 资助金额:
    $ 95.16万
  • 项目类别:
L2M NSERC-Bioengineering attenuated Sclerotinia sclerotiorum strains as bioherbicide for cereal production and lawn management
L2M NSERC-生物工程减毒核盘菌菌株作为谷物生产和草坪管理的生物除草剂
  • 批准号:
    576545-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 95.16万
  • 项目类别:
    Idea to Innovation
Investigating Host and Viral Factors for Improved Design of Future Live Attenuated Vaccines for IBV
研究宿主和病毒因素以改进未来 IBV 减毒活疫苗的设计
  • 批准号:
    BB/V016067/1
  • 财政年份:
    2022
  • 资助金额:
    $ 95.16万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了